BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2895309)

  • 1. Gemfibrozil plus cholestyramine in familial hypercholesterolaemia.
    Jones AF; Hughes EA; Cramb R
    Lancet; 1988 Apr; 1(8588):776. PubMed ID: 2895309
    [No Abstract]   [Full Text] [Related]  

  • 2. Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemia.
    Houlston R; Quiney J; Watts GF; Lewis B
    J R Soc Med; 1988 May; 81(5):274-6. PubMed ID: 3164409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical results with gemfibrozil and background to the Helsinki Heart Study.
    Manninen V
    Am J Cardiol; 1983 Aug; 52(4):35B-38B. PubMed ID: 6351578
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination drug therapy for familial combined hyperlipidemia.
    East C; Bilheimer DW; Grundy SM
    Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. II. Relation between the results of treatment and type of dyslipoproteinemia].
    Sznajd J; Malczewska-Malec M; Idzior-Waluś B; Iwanejko J; Nowacki G
    Przegl Lek; 1987; 44(12):837-43. PubMed ID: 3330253
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma prekallikrein, kallikrein inhibitors, kininogen and lipids during gemfibrozil treatment in type II dyslipidaemia.
    Torstila I; Kaukola S; Manninen V; Virtamo J; Mälkönen M
    Acta Med Scand Suppl; 1982; 668():123-9. PubMed ID: 6188330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
    Weintraub MS; Eisenberg S; Breslow JL
    J Clin Invest; 1987 Apr; 79(4):1110-9. PubMed ID: 3470306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. I. Changes in lipid levels after treatment (the "net" reduction)].
    Sznajd J; Malczewska-Malec M; Idzior-Waluś B; Jamska B; Nowacki G
    Przegl Lek; 1987; 44(12):828-36. PubMed ID: 3330252
    [No Abstract]   [Full Text] [Related]  

  • 9. Gemfibrozil has antilipemic effects on diabetic patients with hyperlipidemia.
    Ho LT; Li SH; Chou TY; Liu YF; Perng JC; Han HK; Chen JJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Jan; 39(1):1-8. PubMed ID: 3484238
    [No Abstract]   [Full Text] [Related]  

  • 10. Gemfibrozil in combination with other drugs for severe hyperlipidemia. Preliminary study comprising four cases.
    Nash DT
    Postgrad Med; 1983 Apr; 73(4):75-82. PubMed ID: 6572892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gemfibrozil on serum lipid levels.
    Dahlén G; Gillnäs T; Børresen AL; Berg K; Ericson C
    Artery; 1980; 7(3):224-31. PubMed ID: 7008748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemfibrozil--a new lipid lowering agent.
    Nash DT
    J Med; 1980; 11(2-3):107-16. PubMed ID: 6931871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemia.
    Wierzbicki AS; Lumb PJ; Cheung J; Crook MA
    QJM; 1997 Oct; 90(10):631-4. PubMed ID: 9415344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical results with gemfibrozil.
    Pickering JE
    Am J Cardiol; 1983 Aug; 52(4):39B-40B. PubMed ID: 6351579
    [No Abstract]   [Full Text] [Related]  

  • 15. The hypolipidemic effect of gemfibrozil on hyperlipidemia in patients with non-insulin-dependent diabetes mellitus.
    Chang DM; Fuh MM; Jeng CY; Shian LR
    Taiwan Yi Xue Hui Za Zhi; 1986 May; 85(5):443-50. PubMed ID: 3463653
    [No Abstract]   [Full Text] [Related]  

  • 16. Nutritional & pharmacologic management of hyperlipoproteinemia.
    Pickering JE
    Angiology; 1982 Sep; 33(9):577-80. PubMed ID: 6957154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemfibrozil in the treatment of dyslipidaemia. A 5-year follow-up study.
    Manninen V; Mälkönen M; Eisalo A; Virtamo J; Tuomilehto J; Kuusisto P
    Acta Med Scand Suppl; 1982; 668():82-7. PubMed ID: 6762809
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of hyperlipidemia with gemfibrozil.
    Hartshorn JC; Deans K
    J Cardiovasc Nurs; 1987 Aug; 1(4):76-80. PubMed ID: 3474354
    [No Abstract]   [Full Text] [Related]  

  • 19. A pilot study of the effect of Gemfibrozil on some haematological parameters.
    O'Brien JR; Etherington MD; Shuttleworth RD; Adams CM; Middleton JE; Goodland FC
    Thromb Res; 1982 May; 26(4):275-9. PubMed ID: 6955993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs recently released in Belgium: mitoxantrone, gemfibrozil.
    Harvengt C
    Acta Clin Belg; 1986; 41(2):127-30. PubMed ID: 3463107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.